Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Though on the Rise, the Transradial Approach to Primary PCI Remains Underused

There is evidence to support the use of the transradial approach to coronary angioplasty. Several randomized studies have shown reduced bleeding and vascular complications when adopted, compared against patients treated with the femoral approach. There are also studies and meta-analysis suggesting that, in the context of primary PCI, the benefit would be even bigger, with significant events rate reduction (even mortality rate).

El uso del acceso radial en la angioplastia primaria crece pero aún no es muy utilizado

This study aims at defining the different patient, operator and institution factors that may or may not contribute to adopting the transradial approach.


Read also: Eficácia do stent de micromalha na angioplastia carotídea”.


The NCDR CathPCI registry included 692,433 patients undergoing primary PCI between 2009 and 2015. Only 12% of these patients (n=82,618) were treated via transracial access site.

 

Even though there are geographical differences, the use of the transradial approach has been increasing, going from 2% in 2009 to 23% in 2015,

 

Age, sex, cardiogenic shock, prior MI, operators starting before 2012, and non-academic institutions, are the factors tilting the scales for the femoral approach.


Read also: A reparação da valva mitral com Mitraclip é segura em pacientes de alto risco”.


When operators choose the transradial access site, there is significant reduction in bleeding, and when institutions adopt it, there is also mortality reduction.

 

Conclusion

Although the transradial approach to primary PCI is growing, it remains largely underused. 

 

Editorial Comment

The present analysis suggests that the evidence in favor of the transradial approach has had a positive impact in use, with a close to ten-fold increase in the last 6 years. However, in the US, figures are far lower than those reported by most European countries. Whether or not Latin America is adopting the transradial approach remains unclear, though intuitively, we should follow our European colleagues.

 

Título original: Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction. Insights from the NCDR CathPCI Registry.

Reference: Javier A. Valle et al. J Am Coll Cardiol Intv 2017. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...